Opevesostat (ODM208)
Product Specifications
CAS Number
2231294-96-3
SKU
C01781-5mg
Target
P450 (e.g. CYP17)
Applications
Metabolism
Additionnal Information
Opevesostat (ODM208) is the first-in-class, selective, nonsteroidal, oral CYP11A1 inhibitor. ODM208 exhibits a rapid, complete, durable, and reversible inhibition of the steroid hormone biosynthesis in an adrenocortical carcinoma cell model in vitro, in adult noncastrated male mice and dogs, and in patients with CRPC.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471461-500 1x 500 µL
CD45 / LCA (B-Cell Marker) (PTPRC/1461), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC426545 20 µg
CCBL1 (KYAT1) (NM_001122671) Human Over-expression Lysate
Sign In for Pricing
View Details 
RG238611 10 µg
GLT25D2 (COLGALT2) (NM_001303421) Human Tagged ORF Clone
Sign In for Pricing
View Details 
![2-(2-Chlorophenyl)-2,3-dihydrobenzo[d]oxazole-5-carboxylic Acid](https://cdn.genprice.uk/products/572/863011607461/imageurl/trc-c723015-10mg.webp)
TRC-C723015-10MG 10 mg
2-(2-Chlorophenyl)-2,3-dihydrobenzo[d]oxazole-5-carboxylic Acid
Sign In for Pricing
View Details